Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Prevalence of Red Cell Pyruvate Kinase Deficiency: A Systematic Literature Review

Mike Storm, MSc, Matthew H Secrest, MSc, Courtney Carrington, MPH, Keely Gilroy, PhD, Leanne Pladson, RN BS, Audra N. Boscoe, PhD, Deborah Casso, MPH

Blood (2019) 134 (Supplement_1): 3513.

https://doi.org/10.1182/blood-2019-124381

Published: 2019

Journal Articles

One-Year Outcomes with Once or Twice Daily Enoxaparin

Adi J. Klil-Drori, MDMSc, Sara Nazha, PhD, Marlene Gharib, PhD, Sylvie Perreault, PhDBPharm, Vicky Tagalakis, MD FRCPC

Blood (2019) 134 (Supplement_1): 4968.

https://doi.org/10.1182/blood-2019-127106

Published: 2019

Journal Articles

Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma

Isabelle Blais-Normandin, MD, Philippe Nadeau, PhD, Linda Vallée, Rémy Angers, BSc, Manon Lescault, Nathalie Laflamme, PhD, Narcisse Singbo, Vincent Laroche, MD

Blood (2019) 134 (Supplement_1): 5635.

https://doi.org/10.1182/blood-2019-122511

Published: 2019

Journal Articles

Gemcitabine, Dexamethasone, Cisplatin +/- Rituximab (GDP +/- R) Is Highly Effective As a Mobilization Regimen in Relapsed or Refractory Lymphoma (COLLYM STUDY)

Jean-Philippe Adam, BPharm, MSc, Vincent T. Taillefer, Pharm.D, Marianne Emond, B.Pharm, M.Sc, BCOP, Marie-Hélène Leblanc, B.Pharm, M.Sc, BCOP, Olivier Besner-Morin, B.Pharm, M.Sc, Stephane Doucet, MD FRCPC

Blood (2018) 132 (Supplement 1): 3348.

https://doi.org/10.1182/blood-2018-99-115539

Published: 2018

Journal Articles

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 910.

https://doi.org/10.1182/blood-2018-99-114525

Published: 2018

Journal Articles

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Alex Iukuridze, Meisi Xiao, MPH, Lee Brandyn, Jennifer Berano Teh, Kristen Mascarenhas, Sandra Xu, Nicholas Rosen, Jeannine S McCune, PharmD, Jasmine M. Zain, MD, Robert W. Chen, MD, Leslie Popplewell, MD, Jessica Scott, PhD, Thomas Slavin, MD, Lee Jones, PhD, Stephen J Forman, Ryotaro Nakamura, MD, F. Lennie Wong, PhD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 620.

https://doi.org/10.1182/blood-2018-99-113689

Published: 2018

Journal Articles

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Annie Lacerte, MD PhD, Marie-Pier Bleau, MD, Jean-Francois Castilloux, MD, Flavia De-angelis, MD, Pierre Desjardins, MD, Michel Pavic, MD, Tamas Fulop, MD PhD

Blood (2018) 132 (Supplement 1): 4213.

https://doi.org/10.1182/blood-2018-99-117640

Published: 2018

Journal Articles

Provincial Disparities in Access to Allogeneic Transplant in Canada

Kristjan Paulson, MD, Oliver Bucher, Geoffrey Cuvelier, MD, Andrew Daly, MD, Alina S. Gerrie, MD MPH, David Sanford, MD, David Szwajcer, MD FRCP(C), Matthew Seftel, MRCP, MD MPH, FRCPC, Irwin Walker, MBBS, Natasha Kekre, MD FRCPC, Tony H Truong, MD FRCPC, Donna Wall, MD CCPE, Kirk R. Schultz, MD, Stephen Couban, MDBSc, Christopher Bredeson, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 4742.

https://doi.org/10.1182/blood-2018-99-113849

Published: 2018

Journal Articles

Comprehensive Single-Cell RNA-Sequencing Mapping of Primary Acute Myeloid Leukemias and Profiling of NPM1-Mutated Cells

Vincent-Philippe Lavallee, MD, Elham Azizi, PhD, Vaidotas Kiseliovas, Ignas Masilionis, Linas Mazutis, PhD, Ross L. Levine, MD, Dana Pe'er, PhD

Blood (2018) 132 (Supplement 1): 995.

https://doi.org/10.1182/blood-2018-99-111390

Published: 2018

Journal Articles

Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation

Adi J. Klil-Drori, MD, Laurent Azoulay, PhD, Rui Nie, MSc, Christel Renoux, MD, PhD, Sharon J. Nessim, MD, MSc, Kristian B. Filion, PhD

Blood (2017) 130 (Supplement 1): 700.

https://doi.org/10.1182/blood.V130.Suppl_1.700.700

Published: 2017

Journal Articles

Transfusion of Sickle Cell Anemia Patients in Quebec: Challenges and Opportunities

Andre Lebrun, MD, Genevieve Myhal, Naderge Ceneston, Jessica Constanzo-Yanez, Yves Grégoire

Blood (2017) 130 (Supplement 1): 3745.

https://doi.org/10.1182/blood.V130.Suppl_1.3745.3745

Published: 2017

Journal Articles

Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation

Saro H. Armenian, DO,MPH, Dongyun Yang, PhD, Jennifer Berano Teh, Brandyn Lee, Howard Chang, Mascarenhas Kristen, Lee Sean, Iukuridze Aleksi, Jack Ji Xie, Jessica Scott, Lee Jones, F. Lennie Wong, Stephen J. Forman, MD, Ryotaro Nakamura

Blood (2017) 130 (Supplement 1): 1991.

https://doi.org/10.1182/blood.V130.Suppl_1.1991.1991

Published: 2017

Journal Articles

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) Compared to Bortezomib-Dexamethasone (Vel-Dex) As Induction Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Claudie Lavoie-Gagnon, MD, Jonathan St-Gelais, MD, Jean-Philippe Adam, BPharm, MSc, BCPS, BCOP, Daniel Viens, MD FRCPC, Félixe Gagné, Pharm.D., MSc, Yann Décarie, MSc, Emilie Lemieux-Blanchard, BSc,MD

Blood (2017) 130 (Supplement 1): 1870.

https://doi.org/10.1182/blood.V130.Suppl_1.1870.1870

Published: 2017

Journal Articles

Persistence with Generic Imatinib for Chronic Myeloid Leukemia: A Matched Cohort Study

Adi J. Klil-Drori, MD, Hui Yin, MSc, Laurent Azoulay, PhD, Alexa Del Corpo, Michael Harnois, Michel-Olivier Gratton, Lambert Busque, MD, Sarit Assouline, MD

Blood (2017) 130 (Supplement 1): 315.

https://doi.org/10.1182/blood.V130.Suppl_1.315.315

Published: 2017

Journal Articles

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Nancy Robitaille, MD, Yves D. Pastore, MD, Anne-Julie Landry, M.Sc, Catherine Latour, MD, Josée Lavoie, M.Sc, Geneviève Laflamme, M.Sc, Josée Perreault, PhD, Maryse St-Louis, PhD

Blood (2016) 128 (22): 2486.

https://doi.org/10.1182/blood.V128.22.2486.2486

Published: 2016

Journal Articles

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Adi J. Klil-Drori, MD, Janie Coulombe, MSc, Sharon J. Nessim, MD MSc, Vicky Tagalakis, MD MSc

Blood (2016) 128 (22): 89.

https://doi.org/10.1182/blood.V128.22.89.89

Published: 2016

Journal Articles

Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries

Christopher M Hillis, MD FRCPC, Lambert Busque, MD PhD FRCPC, Julie Stakiw, MD, Donna L. Forrest, MD FRCPC

Blood (2016) 128 (22): 3079.

https://doi.org/10.1182/blood.V128.22.3079.3079

Published: 2016

Journal Articles

Retrospective Study of Intravascular Lymphoma Cases Diagnosed in Quebec

Vanessa Brunet, MD, Michel Pavic, MD, Sofia Marouan, MD, Jean Pierre Routy, MD, Mohamed Amin Hashem, MD, Vincent Bernier, MD, Raynald Simard, MD, Tony Petrella, MD, Louis Lamarre, MD, Gilles Théorêt, MD, Christian Carrier, MD, Hans Knecht, MD, Isabelle Fleury, MD

Blood (2016) 128 (22): 3046.

https://doi.org/10.1182/blood.V128.22.3046.3046

Published: 2016

Journal Articles

Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study

Susan R Kahn, MD MSc, Andrew Hirsch, MD, Margaret Beddaoui, MSc, Arash Akaberi, MSc, David Anderson, MD, Philip S Wells, MDMSc, Marc Rodger, MD MSc, Susan Solymoss, MD, Michael J. Kovacs, MD, Lawrence Rudski, MD, Avi Shimony, MD, Carole Dennie, MD, Chris Rush, MD, William H. Geerts, MD, Paul Hernandez, MD, Shawn Aaron, MD, John T Granton, MD

Blood (2015) 126 (23): 649.

https://doi.org/10.1182/blood.V126.23.649.649

Published: 2015

Journal Articles

Influence of Prophylactic Antibiotics Aiming at Gut Decontamination on Gastrointestinal Graft-Versus-Host Disease and Overall Survival Following Allogeneic Haematopoietic Stem Cell Transplantation

Bertrand Routy, MD, Caroline Letendre, MD, Maxime Chenard-Poirier, MD, Vikram Mehraj, PhD, David Enot, Khaled Guenda, MD, Noemie Charbonneau Séguin, Kathia Gagnon, Silvy Lachance, MD

Blood (2015) 126 (23): 4319.

https://doi.org/10.1182/blood.V126.23.4319.4319

Published: 2015

NARROW

Prevalence of Red Cell Pyruvate Kinase Deficiency: A Systematic Literature Review

One-Year Outcomes with Once or Twice Daily Enoxaparin

Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma

Gemcitabine, Dexamethasone, Cisplatin +/- Rituximab (GDP +/- R) Is Highly Effective As a Mobilization Regimen in Relapsed or Refractory Lymphoma (COLLYM STUDY)

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia

Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Provincial Disparities in Access to Allogeneic Transplant in Canada

Comprehensive Single-Cell RNA-Sequencing Mapping of Primary Acute Myeloid Leukemias and Profiling of NPM1-Mutated Cells

Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation

Transfusion of Sickle Cell Anemia Patients in Quebec: Challenges and Opportunities

Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) Compared to Bortezomib-Dexamethasone (Vel-Dex) As Induction Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Persistence with Generic Imatinib for Chronic Myeloid Leukemia: A Matched Cohort Study

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries

Retrospective Study of Intravascular Lymphoma Cases Diagnosed in Quebec

Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study

Influence of Prophylactic Antibiotics Aiming at Gut Decontamination on Gastrointestinal Graft-Versus-Host Disease and Overall Survival Following Allogeneic Haematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only